These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31904216)

  • 1. DARK Classics in Chemical Neuroscience: Kava.
    Volgin A; Yang L; Amstislavskaya T; Demin K; Wang D; Yan D; Wang J; Wang M; Alpyshov E; Hu G; Serikuly N; Shevyrin V; Wappler-Guzzetta E; de Abreu M; Kalueff A
    ACS Chem Neurosci; 2020 Jan; ():. PubMed ID: 31904216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
    Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
    Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and physiological effects of acute and chronic kava exposure in adult zebrafish.
    Wang D; Yang L; Wang J; Hu G; Liu Z; Yan D; Serikuly N; Alpyshov ET; Demin KA; Galstyan DS; Strekalova T; de Abreu MS; Amstislavskaya TG; Kalueff AV
    Neurotoxicol Teratol; 2020; 79():106881. PubMed ID: 32240749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
    Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
    J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthetic origin of psychoactive kavalactones in kava.
    Pluskal T; Torrens-Spence MP; Fallon TR; De Abreu A; Shi CH; Weng JK
    Nat Plants; 2019 Aug; 5(8):867-878. PubMed ID: 31332312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kavalactones from Kava (Piper methysticum) root extract as modulators of recombinant human glycine receptors.
    Hegazy NH; Breitinger HG; Breitinger U
    Biol Chem; 2019 Aug; 400(9):1205-1215. PubMed ID: 31141476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (
    Wang Y; Su C; Zhang B; Niu Y; Ren R; Zhao X; Yang L; Zhang W; Ma X
    Evid Based Complement Alternat Med; 2021; 2021():6851798. PubMed ID: 34471418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.
    Soares RB; Dinis-Oliveira RJ; Oliveira NG
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of kavalactones from Piper methysticum (kava-kava).
    Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.
    Showman AF; Baker JD; Linares C; Naeole CK; Borris R; Johnston E; Konanui J; Turner H
    Fitoterapia; 2015 Jan; 100():56-67. PubMed ID: 25464054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.
    Wang J; Qu W; Bittenbender HC; Li QX
    J Food Sci Technol; 2015 Feb; 52(2):1164-9. PubMed ID: 25694734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanogenesis stimulation in murine B16 melanoma cells by Kava (Piper methysticum) rhizome extract and kavalactones.
    Matsuda H; Hirata N; Kawaguchi Y; Naruto S; Takata T; Oyama M; Iinuma M; Kubo M
    Biol Pharm Bull; 2006 Apr; 29(4):834-7. PubMed ID: 16595931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC).
    Lebot V; Do TK; Legendre L
    Food Chem; 2014 May; 151():554-60. PubMed ID: 24423570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
    Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
    Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
    Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T
    J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Behavioral Assay to Examine the Effects of Kavalactones on
    Kautu BB; Chappel J; Steele K; Phillips J; Mengarelli SM
    Bio Protoc; 2018 Sep; 8(18):e3008. PubMed ID: 34395799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.